Posizioni attive di Jonathan Hahn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Tuteur SA | Direttore/Membro del Consiglio | 01/01/2013 | - |
| Presidente | 01/01/2013 | - | |
| Corporate Officer/Principal | 01/01/2013 | - | |
| Tuteur SACIFIA | Direttore/Membro del Consiglio | 01/01/2013 | - |
| Presidente | 01/01/2013 | - |
Storia della carriera di Jonathan Hahn
Precedenti posizioni note di Jonathan Hahn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | - | - |
| KAMADA LTD. | Direttore/Membro del Consiglio | 25/03/2010 | - |
Formazione di Jonathan Hahn
| University of San Andres | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Argentina | 4 |
| Stati Uniti | 3 |
| Israele | 2 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| President | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KAMADA LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Tuteur SA | |
| Tuteur SACIFIA |
- Borsa valori
- Insiders
- Jonathan Hahn
- Esperienza
